Survival analysis further indicated a correlation between elevated CHI3L1 expression and reduced survival rates.<h4>Conclusion</h4>This study identified that CHI3L1 was an oncogene in PTC and promotes tumor cell proliferation associated with downregulating the TP53 pathway. The gene discussed is CHI3L1; the disease is neoplasm.